India  

Bharat Biotech

Indian biotechnology company and vaccine manufacturer

Bharat Biotech    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Bharat Biotech: Indian biotechnology company and vaccine manufacturer
Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products.

0
shares
ShareTweetSavePostSend
 

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get..

Credit: ANI     Duration: 01:28Published
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based..

Credit: ANI     Duration: 01:30Published
Covid vaccine: How many Indians got jab on Day 1? Govt reveals [Video]

Covid vaccine: How many Indians got jab on Day 1? Govt reveals

At least 1,65,714 healthcare beneficiaries received COVID-19 jab on Saturday across India, marking it as a historic and biggest COVID-19 vaccination drive launched by Prime Minister Narendra Modi...

Credit: HT Digital Content     Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made..

Credit: HT Digital Content     Duration: 08:15Published
Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine [Video]

Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine

Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the..

Credit: HT Digital Content     Duration: 03:41Published
Vaccine will work as 'sanjeevani' in fight against COVID-19: Harsh Vardhan [Video]

Vaccine will work as 'sanjeevani' in fight against COVID-19: Harsh Vardhan

After Prime Minister Narendra Modi launched nation-wide vaccination drive against COVID-19 on January 16 via video conferencing. Union Health Minister Dr Harsh Vardhan on Saturday said the vaccine will..

Credit: ANI     Duration: 01:42Published
'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive [Video]

'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive

Union health minister Dr Harsh Vardhan said that the vaccination drive is 'beginning of the end of covid-19'. He reviewed the preparedness ahead of the Covid-19 vaccination drive in India. "World's..

Credit: HT Digital Content     Duration: 03:02Published
‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist [Video]

‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist

Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants. Panda added that India has taken a smart..

Credit: HT Digital Content     Duration: 04:36Published
Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch [Video]

Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch

Delhi Chief Minister Arvind Kejriwal commented on the impending launch of mass immunisation against Covid-19. India will begin vaccinations on January 16. Vaccines are being shipped to various centres..

Credit: HT Digital Content     Duration: 02:39Published
Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield [Video]

Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield

The first batch of Covaxin landed at the Delhi airport from Hyderabad on January 13. The Covid-19 vaccine by Bharat Biotech was brought in by two flights. An Air India flight landed with 3 boxes while..

Credit: HT Digital Content     Duration: 02:02Published
First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport [Video]

First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport

The first consignment of 'Covaxin', the COVID-19 vaccine by Hyderabad-based Bharat Biotech arrived at Delhi's Indira Gandhi International Airport on Jan 13. Three boxes of 'Covaxin' are also being..

Credit: ANI     Duration: 01:18Published
Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out [Video]

Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out

Several states in India received the vaccine doses on January 12. Consignment of Covishield was dispatched from Serum Institute of India, Pune. States that received vaccines on January 12 include..

Credit: HT Digital Content     Duration: 03:31Published
BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry [Video]

BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry

Bharat Biotech to provide 16.50 lakh doses of COVAXIN for free of cost to the Central government as a special gesture, informed Union Health Ministry during a press briefing on January 12. "The..

Credit: ANI     Duration: 01:23Published
These temperature-controlled trucks set to transport COVID vaccine from Serum Institute of India [Video]

These temperature-controlled trucks set to transport COVID vaccine from Serum Institute of India

As COVID-19 vaccination drive in India is set to rollout on January 16, the responsibility to transport the Covishield vaccine from Serum Institute of India's main hub to government depots is given to..

Credit: ANI     Duration: 03:09Published
Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move [Video]

Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move

On the day that the Union government announced the launch date of Covid-19 vaccination in the country, Chhattisgarh health minister TS Singh Deo made an appeal. The Congress leader said that the Centre..

Credit: HT Digital Content     Duration: 03:58Published

You Might Like


Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

India's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the..
IndiaTimes - Published

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech,..
IndiaTimes - Published

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. ​​Out of the 45 lakh doses, the city-based vaccine..
IndiaTimes - Published

COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow

Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
DNA - Published

COVID-19: Bharat Biotech to pay compensation for any side effect of Covaxin, details here

Bharat Biotech, has received a government purchase order for the supply of 55 lakh doses of Covaxin.
DNA - Published

Compensation if Covaxin causes serious adverse effect

Beneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally related to the vaccine. Beneficiaries of..
IndiaTimes - Published

India plans 20 million doses of vaccine supply to neighbours

India plans to offer 20 million doses of coronavirus vaccine to its neighbours as it draws up a policy to supply vials to countries across the globe, people with knowledge of the matter said. An Indian..
IndiaTimes - Published

Experts question govt vaccine purchase price, say it’s higher

As the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s..
IndiaTimes - Published

Vaccine drive accelerates, doses reach far corners of India

While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
IndiaTimes - Published

Bharat Biotech commences dispatch of Covaxin, ships to 11 cities

Vaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown out of Hyderabad by national carrier..
IndiaTimes - Published

After Covishield, first batch of Bharat Biotech's Covaxin arrives in Delhi

Both Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government.
DNA - Published

Covid vaccine recipients may not be able to pick & choose

Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they..
IndiaTimes - Published

Bharat Biotech inks pact to supply Covaxin to Brazil

Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian..
IndiaTimes - Published

54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: Centre

The Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of..
IndiaTimes - Published

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-March

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new..
IndiaTimes - Published

Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials


IndiaTimes - Published

All-India vaccine rollout set for next week: Govt

The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
IndiaTimes - Published

Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccines

Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of Covid-19 vaccines in the country and the world.
IndiaTimes - Published

Why Covaxin may have an edge against new virus variants

The chairman and managing director of Bharat Biotech, Dr Kishna Ella, said its Covid-19 vaccine, Covaxin, would be effective on mutant strains of the coronavirus, and therefore is justified to receive..
IndiaTimes - Published

Carried out 200% honest trials, don't deserve this backlash: Bharat Biotech hits back at critics

Some opposition leaders and scientific researchers criticised Covaxin for being given emergency use authorisation without completion of phase 3 trials
DNA - Published

Vaccine war: Bharat Biotech chief lashes out at Serum

Bharat Biotech founder and chairman Dr Krishna Ella on Monday lashed out at detractors who criticised the speed at which emergency use authorisation (EUA) was given to Covaxin, the company’s Covid-19..
IndiaTimes - Published

Covaxin not water-like or backup vaccine, trials 200% honest: Bharat Biotech CEO


IndiaTimes - Published

Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021

The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday. "We have four facilities coming up and we are planning (to make) around 200 million doses in..
IndiaTimes - Published

Centre taking up Covid-19 vaccination in a big way: Harsh Vardhan

Union health and family welfare minister Dr Harsh Vardhan on Monday said the Centre has initiated a series of actions to prevent the spread of coronavirus and that it is now taking up the vaccination..
IndiaTimes - Published

DCGI allows Bharat Biotech to conduct vaccine trials on children above 12

Covaxin has already been used on children above 12 in phase I and II trials and has been found safe.
DNA - Published

Brazil private clinics seek deal for Indian Covid vaccine

A Brazilian association of private health clinics said Sunday it was negotiating with Indian pharmaceutical firm Bharat Biotech to buy five million doses of its Covid-19 vaccine, which India has just..
IndiaTimes - Published

Coronavirus vaccine price: SII CEO reveals how much it will cost

COVID-19 vaccines of Serum Institue of India and Bharat Biotech were granted permission for restricted use in an emergency situation on Sunday.
DNA - Published

Submitted all data as per guidelines, says Bharat Biotech


IndiaTimes - Published

Bharat Biotech vaccine more likely to work against newer strains like UK variant: Vardhan


IndiaTimes - Published

ICMR says clinical trial shows COVAXIN is 'safe'

Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
DNA - Published

Govt must explain why international protocols were disregarded to approve Bharat Biotech’s Covaxin, Congress leaders say


IndiaTimes - Published

Opposition parties not proud of anything Indian, alleges Nadda as Congress and BJP spar over Covid vaccine issue

The BJP on Sunday hit out at the Congress after some of its leaders questioned the approval process for Bharat Biotech's Covid-19 vaccine, with party president J P Nadda alleging that whenever India..
IndiaTimes - Published

WHO welcomes India's emergency use authorisation approval to COVID-19 vaccines

The COVID-19 vaccines of the Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.
DNA - Published

Great milestone in India's scientific capability: Bharat Biotech after DCGI approval to Covaxin

The Hyderabad-based vaccine maker expressed its delight after DCGI granted permission for emergency use of its Covid-19 vaccine.
DNA - Published

'Watershed moment in India's battle against COVID': Politicos react over emergency use approval

DCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
DNA - Published

India approves Oxford's, Bharat Biotech's Covid-19 vaccines for restricted emergency use


IndiaTimes - Published

Congress leaders raise concern over grant of permission for restricted use of Covid-19 vaccine

Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's Covid-19 vaccine and asked the government to..
IndiaTimes - Published

BREAKING: DCGI grants approval to Serum Institute, Bharat Biotech's COVID-19 vaccines

The approval comes after the clearances from the Subject Expert Committee (SEC).
DNA - Published

COVID-19: Bharat Biotech recruits 23,000 volunteers for Phase III trials of Covaxin

The phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.
DNA - Published Also reported by •IndiaTimes

Bharat Biotech’s Covaxin too gets nod for emergency use

India's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
IndiaTimes - Published

After Covishield, India's Covaxin gets expert panel nod for emergency use

An expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use..
IndiaTimes - Published

CDSCO panel recommends granting approval for Bharat Biotech's Covaxin


IndiaTimes - Published

Covaxin vaccine: DCGI panel to meet Bharat Biotech officials shortly


IndiaTimes - Published

No approval for Covaxin, expert panel seeks more data from Bharat Biotech

The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for..
IndiaTimes - Published

UK approves Oxford vaccine, raising hopes for India rollout

India's subject expert committee that met on Wednesday sought more data relating to the vaccine's immunogenicity, which will mean the emergency-use approval may take a few more days. The committee is..
IndiaTimes - Published

Covaxin can offer protection against mutated coronavirus: Bharat Biotech

Vaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain.
DNA - Published

Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah Naidu

They discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans..
IndiaTimes - Published Also reported by •DNA

Indian vaccine Covaxin has drawn global attention: ICMR

The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against..
IndiaTimes - Published

Antibodies generated by Covaxin may persist for 6-12 months: Bharat Biotech


IndiaTimes - Published

Covaxin Phase III trials hit halfway mark with 13K volunteers

Covaxin, India's first indigenous Covid-19 vaccine being developed by Hyderabad-based Bharat Biotech, has been successful in roping in 13,000 volunteers for its Phase III trials, which is half the..
IndiaTimes - Published


 Page 1  〉